Variation of Sequential Ligandrol (LGD-4033) Metabolite Levels in Routine Anti-Doping Urine Samples Detected with or without Other Xenobiotics
Molecules · 2023
DOI: 10.3390/molecules28186486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Dorota Kwiatkowska und 5 weiteren Autor:innen. Beteiligte Einrichtung: Polish Anti-Doping Laboratory, Ksiecia Ziemowita 53 Bud. 4, 03-885 Warsaw, Poland. Hauptthemen laut MEDLINE: Doping in Sports. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health of the Republic of Poland.
Abstract (Originalsprache)
Ligandrol, also known as LGD-4033, belongs to the group of selective androgen receptor modulators (SARMs). Ligandrol was first included in the WADA Prohibited List in 2018. This work presents a method that allows for the detection and identification of ligandrol and its metabolite in athletes’ urine and in dietary supplements by means of ultra performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS). Samples were prepared according to an approach involving acid hydrolysis and double liquid–liquid extraction (LLE). Furthermore, due to the lack of reference material for ligandrol metabolites, the urine collected from the control excretion study was analyzed. The presented method is appropriate to monitor ligandrol and its metabolites. The samples collected for doping control purpose contained multiple metabolites, which may potentially rule out the hypothesis of ingesting a single 1 µg or 10 µg dose only. Another aspect to take into account is that ligandrol can be applied together with SARMs, steroids, and GHSs. This will also affect the substances’ metabolism and elimination. It is also worth noting that dietary supplements may contain ligandrol as an official ingredient or as a contaminant. The described method may be usefully applied by other anti-doping or toxicological laboratories.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Polish Anti-Doping Laboratory, Ksiecia Ziemowita 53 Bud. 4, 03-885 Warsaw, Poland.
- Biological and Chemical Research Centre, University of Warsaw, Zwirki i Wigury 101, 02-093 Warsaw, Poland.
ORCID-Profile: Dorota Kwiatkowska, Mariola Wicka, Patryk Konarski
Förderung
- Ministry of Health of the Republic of Poland
Zitieren
APA
Kwiatkowska, D., Wicka, M., Grucza, K., Konarski, P., Drapała, A., & Kaliszewski, P. (2023). Variation of Sequential Ligandrol (LGD-4033) Metabolite Levels in Routine Anti-Doping Urine Samples Detected with or without Other Xenobiotics. Molecules. https://doi.org/10.3390/molecules28186486
Vancouver
Kwiatkowska D, Wicka M, Grucza K, Konarski P, Drapała A, Kaliszewski P. Variation of Sequential Ligandrol (LGD-4033) Metabolite Levels in Routine Anti-Doping Urine Samples Detected with or without Other Xenobiotics. Molecules. 2023. doi:10.3390/molecules28186486
BibTeX
@article{Kwiatkowska2023,
author = {Kwiatkowska, Dorota and Wicka, Mariola and Grucza, Krzysztof and Konarski, Patryk and Drapała, Aleksandra and Kaliszewski, Paweł},
title = {Variation of Sequential Ligandrol (LGD-4033) Metabolite Levels in Routine Anti-Doping Urine Samples Detected with or without Other Xenobiotics},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28186486}
}
EUVIMED